While our study sheds some light on the effect NF‐κB and GDF‐15 may have on prostate tumor development in the time just before malignant transformation, more modeling of the premalignant setting is needed to determine the dynamic changes in inflammatory mediators that initiate and support malignancy in prostate. This evidence concerns the gene NFKB1 and prostate neoplasm.